FDA
approval
· 2021-04-28
FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (FOSUN PHARMA USA INC)
Summary
FDA approved a supplemental application for ketorolac tromethamine from Fosun Pharma USA Inc, under the ANDA pathway.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)